Download Files:
Products Details
Product Description
– c-Fms-IN-7 is a cFMS inhibitor extracted from patent WO2011079076A1, example159, has an IC50 of 18.5 nM[1].
Web ID
– HY-111948
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C26H24N6OS
References
– [1]Mark Laurence Boys，et al. Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors. WO2011079076A1
CAS Number
– 1313408-89-7
Molecular Weight
– 468.57
SMILES
– O=C(C1=CN=C2C=C(SC)C=CN21)NC3=CC=CC4=C3C(C5CC5)=NN4CC6=NC(C)=CC=C6
Clinical Information
– No Development Reported
Research Area
– Cancer; Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– c-Fms
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
